Lawmakers hear AB 304 on electromagnetic brain‑pulse treatment pilot and reporting; supporters cite addiction and mental‑health benefits

Assembly Bill 304 would require data collection and quarterly reporting on a pilot program for electromagnetic brain‑pulse (EMBP) treatments, the sponsor told the Senate Finance Committee on June 1.

Assemblymember Venise Karas (transcript shows as Karas/Karas) described EMBP as devices and procedures that image and stimulate electrical brain activity to restore function using non‑pharmaceutical, noninvasive methods. "Research has shown this treatment can effectively treat neuropsychiatric disorders, including major depressive disorder, anxiety, and substance use disorders and addictions," she said. Karas told the committee an amendment removed a previously large fiscal note, and she provided letters stating counties and municipalities had reported no fiscal impact on implementation.

Supporters included the Reno‑Sparks Chamber of Commerce, the Nevada Opioid Treatment Association and the Vegas Chamber; supporters argued the technology has potential benefit for opioid use disorder and behavioral‑health conditions. Tom Clark of the Reno‑Sparks Chamber said local insurance providers are exploring coverage for EMBP at a Reno clinic and described positive results.

One caller listed opposition on the phone queue earlier in the record but no sustained opposition testimony was delivered in person; the committee took no recorded vote. The hearing closed with the sponsor noting the bill's emphasis on data, oversight and pilot evaluation.